Below are the most recent publications written about "Ophthalmic Solutions" by people in Profiles.
-
Mak G, Speck CC, Kar I, Rhee DJ. Implementation of a multidose ophthalmic medication policy change at a large health system. J Am Pharm Assoc (2003). 2025 May-Jun; 65(3):102356.
-
Lin CC, Chamberlain W, Benetz BA, Gensheimer W, Li JY, Jeng BH, Clover J, Varnado N, Abdelrahman S, Srinivasan A, Syed ZA, Koo EH, Arnold BF, Lietman TM, Lass J, Rose-Nussbaumer J. Descemet Endothelial Thickness Comparison Trial II (DETECT II): multicentre, outcome assessor-masked, placebo-controlled trial comparing Descemet membrane endothelial keratoplasty (DMEK) to Descemet stripping only (DSO) with adjunctive ripasudil for Fuchs dystrophy. BMJ Open Ophthalmol. 2024 10 01; 9(1).
-
Rhee DJ, Sancheti H, Rothman AL, Herndon L, Brubaker JW, Patrianakos T, Radcliffe N, Zhang AD, Szczotka-Flynn L. Primary Practice Patterns for the Initial Management of Open Angle Glaucoma. J Glaucoma. 2024 09 01; 33(9):671-678.
-
Leventer I, Singh H, Pashaee B, Raimondo CD, Khakh CK, Martin JL, Acharya B, Zhang Q, Lally SE, Shields CL. Topical 5-fluorouracil 1% for moderate to extensive ocular surface squamous neoplasia in 73 consecutive patients: Primary versus secondary treatment. Asia Pac J Ophthalmol (Phila). 2024 Mar-Apr; 13(2):100052.
-
Wakabayashi T, Mansour HA, Abishek RM, Sridhar J, Cohen MN, Xu D, Deaner J, Yonekawa Y, Hsu J, Kuriyan AE. Google Search Trends to assess public interest in and concern about Vuity for treating presbyopia. PLoS One. 2023; 18(10):e0293066.
-
Ali A, Bielory L, Dotchin S, Hamel P, Strube YNJ, Koo EB. Management of vernal keratoconjunctivitis: Navigating a changing treatment landscape. Surv Ophthalmol. 2024 Mar-Apr; 69(2):265-278.
-
Boyer DS, Kaiser PK, Magrath GN, Brady K, Edwards S, Tanzer DJ, Heier JS. The Safety and Biological Activity of OTT166, a Novel Topical Selective Integrin Inhibitor for the Treatment of Diabetic Eye Disease: A Phase 1b Study. Ophthalmic Surg Lasers Imaging Retina. 2022 10; 53(10):553-560.
-
Shields CL, Paulose SA, Yaghy A, Dalvin LA, Constantinescu AB, Lally SE, Shields JA. Ocular Surface Squamous Neoplasia Managed With Primary Interferon a2b: A Comparative Analysis of 212 Tumors in Smokers Versus Nonsmokers. Cornea. 2021 Nov 01; 40(11):1387-1394.
-
Janeczko P, Norris MR, Bielory L. Assessment of receptor affinities of ophthalmic and systemic agents in dry eye disease. Curr Opin Allergy Clin Immunol. 2021 10 01; 21(5):480-485.
-
Shiuey EJ, Mehran NA, Ustaoglu M, Zhang Q, Razeghinejad R, Shukla AG, Kolomeyer NN, Myers JS, Lee D. The effectiveness and safety profile of netarsudil 0.02% in glaucoma treatment: real-world 6-month outcomes. Graefes Arch Clin Exp Ophthalmol. 2022 Mar; 260(3):967-974.